InnovexLab Wound panel
Bacteria, including anaerobes, fungi and viruses identified directly from wound swabs or tissue, with a reflex antibiotic-resistance gene panel.
General medical information for education only, not medical advice. Targets as listed on InnovexLab’s requisition forms (wound requisition form). Detection of a target does not by itself establish infection or determine treatment; results are interpreted by the ordering clinician with the clinical picture and, where indicated, culture and susceptibility testing.
When to consider testing
Wounds with clinical signs of infection: spreading erythema, warmth, swelling, purulence, increasing pain, malodor or a stalled wound. Collect after cleansing and debridement, from viable tissue where possible.
Interpretation
Chronic wounds are colonized by many organisms; detection is interpreted with the clinical exam. A resistance gene cannot be assigned to one organism in a mixed specimen.
Targets (44)
Select a target for its clinical summary, symptoms, resistance and treatment considerations.
Gram-negative bacteria (13)
- Escherichia coliA normal inhabitant of the human gut and the most common cause of urinary tract infection.
- Klebsiella pneumoniaeAn encapsulated gut organism and a major cause of healthcare-associated infection, frequently carrying resistance genes.
- Klebsiella oxytocaA Klebsiella species found in the gut and the healthcare environment.
- Klebsiella aerogenesA healthcare-associated Gram-negative rod, often in catheterized or ventilated patients.
- Enterobacter cloacaeGram-negative rods common in healthcare settings, notable for inducible AmpC beta-lactamase.
- Citrobacter freundiiA gut and environmental Gram-negative rod causing opportunistic infection.
- Proteus mirabilisMotile, urease-producing Gram-negative rods.
- Proteus vulgarisMotile, urease-producing Gram-negative rods.
- Morganella morganiiA urease-producing Gram-negative rod causing opportunistic and healthcare-associated infection.
- Pseudomonas aeruginosaA non-fermenting Gram-negative rod thriving in moist environments; a major healthcare-associated pathogen.
- Acinetobacter baumanniiA Gram-negative coccobacillus that survives on dry surfaces and causes healthcare-associated outbreaks.
- Kingella kingaeA Gram-negative coccobacillus that colonizes the throat of young children.
- Bacteroides fragilis (anaerobe)An anaerobic Gram-negative rod and the most frequent anaerobe in serious infections; part of the normal colon flora.
Gram-positive bacteria (7)
- Staphylococcus aureusA Gram-positive coccus in clusters carried on the skin and in the nose of many people, and a major cause of skin, soft-tissue and invasive infection.
- Staphylococcus saprophyticusA coagulase-negative staphylococcus and a common cause of cystitis in young, sexually active women.
- Enterococcus faecalisA Gram-positive coccus in pairs and short chains from the gut; hardy in the healthcare environment.
- Enterococcus faeciumA gut enterococcus and the species most often resistant to vancomycin (VRE).
- Clostridium perfringens (anaerobe)Spore-forming anaerobic Gram-positive rods from soil and the gut that produce tissue-damaging toxins.
- Clostridium septicum (anaerobe)Spore-forming anaerobic Gram-positive rods from soil and the gut that produce tissue-damaging toxins.
- Clostridium novyi (anaerobe)Spore-forming anaerobic Gram-positive rods from soil and the gut that produce tissue-damaging toxins.
Fungi (11)
- Candida albicansThe most common Candida yeast, part of normal oral, gut and vaginal flora.
- Candida aurisAn emerging, often multidrug-resistant yeast that spreads in healthcare facilities, particularly long-term and ventilator care.
- Candida glabrataNon-albicans Candida species, increasingly common in vaginal, urinary and invasive infection, with species-specific antifungal patterns.
- Candida kruseiNon-albicans Candida species, increasingly common in vaginal, urinary and invasive infection, with species-specific antifungal patterns.
- Candida lusitaniaeNon-albicans Candida species, increasingly common in vaginal, urinary and invasive infection, with species-specific antifungal patterns.
- Candida parapsilosisNon-albicans Candida species, increasingly common in vaginal, urinary and invasive infection, with species-specific antifungal patterns.
- Candida tropicalisNon-albicans Candida species, increasingly common in vaginal, urinary and invasive infection, with species-specific antifungal patterns.
- Fusarium solaniAn environmental mold and a cause of non-dermatophyte nail and eye infection.
- Trichophyton interdigitaleFungi that infect keratin in skin, hair and nails, and the main cause of onychomycosis and tinea.
- Aspergillus terreusEnvironmental molds found in soil and decaying matter.
- Aspergillus nigerEnvironmental molds found in soil and decaying matter.
Viruses (5)
- Herpes simplex virus 1DNA viruses that establish lifelong latent infection and reactivate.
- Herpes simplex virus 2DNA viruses that establish lifelong latent infection and reactivate.
- Human papillomavirus 16High-risk HPV types that cause most cervical cancers and many anal and oropharyngeal cancers.
- Human papillomavirus 18High-risk HPV types that cause most cervical cancers and many anal and oropharyngeal cancers.
- Varicella-zoster virus (HHV-3)The DNA virus that causes chickenpox and later reactivates as shingles (herpes zoster).
Reflex antibiotic-resistance genes (8)
- AmpC
- mecA, femA
- qnrA, qnrB
- vanA1, vanA2, vanB
- NDM, KPC, OXA-48, VIM, IMP-7
- SHV, TEM, CTX-M1, CTX-M2
- ermA, ermB
- mefA
Sources
- IDSA. Skin and Soft Tissue Infections guideline.
- IDSA / IWGDF. Diabetic Foot Infections guideline.
- CDC. MRSA.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.